Alain CornetPhase IIB Clinical Trial of Voclosporin Successfully Achieves Primary Endpoint Good news posted yesterday on the Lupus Foundation of America website. To see the full article please click here. “(Washington DC – August 15) Today Aurinia Pharmaceutical Company announced positive top-line results of a Phase IIB clinical study of voclosporin, a potential new therapy option for […]
Alain CornetEPF launches its survey on Access to Healthcare. This is a project that LUPUS EUROPE has been actively involved in as a participant in the Access to Healthcare work group at EPF. Designed by patients and patient representatives, EPF launches a unique survey on access to healthcare. Share your experience on access and help us […]
✅ #Rosacea versus #LUPUS ⬇️
Practical tips for distinguishing the 2 conditions 👍
🚨𝗗𝗲𝗮𝗱𝗹𝗶𝗻𝗲 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗶𝗻𝗴 𝗙𝗮𝘀𝘁❗
Please take part in the Living With Lupus in 2024 survey.
🗣️ Your insights are crucial for capturing the diverse experiences of those living with #lupus across Europe.
🧵Find the link for all 21 languages in this thread ⤵️
✅ Management of #glucocorticoids at the 4th advanced workshop on #Lupus by @SLEuroSociety by J Delgado Alves:
- Main mechanisms of action
- Optimal starting dose (organ- and severity driven)
- Tapering strategy (how fast/additional medications?)
- Stopping? (Yes/no/who?)
🔥 #SLE #lupus patients: Be part of the conversation. Let your voice be heard.
What is it like living with lupus?
Help @LupusEurope learn more about lupus patients so the rest of us know what you are going through
✅ Today is the start of the 4th @SLEuroSociety Advanced #Lupus #Workshop, an event created when I became President of the European Lupus Society. We bring together 30 lucky participants + an amazing faculty for 2 days of intensive & collective discussion of complex #SLE cases 👍
✍🏻Пройдіть опитування.
🔊Поділіться з вашою громадою.
👨🏼⚕Якщо ви медичний працівник і лікуєте пацієнтів з лупусом в Європі, ми були б дуже вдячні, якби ви поінформували своїх пацієнтів.
https://buff.ly/3xIyiBy
📣 One week left to register for our online EUPATI Essentials Training! 📣
Are you an industry, academia or consortium member wanting to enhance your knowledge on patient engagement?
🎯 Register now ▶️ https://bit.ly/4auAmen
#EUPATI #Essentials #OnlineTraining #RegisterToday
My absolute pleasure to work with @Lupusreference CC Mok and Talia for this nice review, prepared for the general medical community to better understand Dx challenge and Mx of SLE. Lots we can do to improve outcomes inc comorbidity burden! https://authors.elsevier.com/a/1ixq7V-4XOrME
♦️ Few days left to fill the Living With Lupus in 2024 survey!
✍🏻Doe mee aan de enquête.
🔊Deel met uw gemeenschap.
🙏 Help us and NVLE achieve more answers to ensure that the Dutch population is represented in the results
buff.ly/3xGBU6T
0 CommentsComment on Facebook
♦️ Few days left to fill the Living With Lupus in 2024 survey!
✍🏻Deltag i undersøgelsen.
🔊Del med dit fællesskab.
👨🏼⚕Hvis du er sundhedsprofessionel og behandler patienter med lupus i Europa, ville vi sætte stor pris på, at du informerer dine patienter.
🙏 Help us and Sle-Lupus- info achieve more answers to ensure that the Danish population is represented in the results
s.surveylegend.com/-NqmjTjyUXHGLMmAu5qS
0 CommentsComment on Facebook
♦️ Few days left to fill the Living With Lupus in 2024 survey!
✍🏻Dalyvaukite apklausoje.
🔊Dalinkitės savo bendruomenėje
👨🏼⚕Jeigu esate sveikatos priežiūros specialistas ir gydote vilklige sergančius pacientus Europoje, būtume labai dėkingi, jei informuotumėte savo pacientus.
🙏 Help us and Lupus Lt achieve more answers to ensure that the Lithuanian population is represented in the results
s.surveylegend.com/-NqwWcQ0UhyMxDtCBYRD
0 CommentsComment on Facebook
✍🏻Doe mee aan de enquête.
🔊Deel met uw gemeenschap.
👨🏼⚕Bent u een gezondheidsmedewerker en behandelt u lupuspatiënten in Europa, dan waarderen we het zeer als u uw patiënten deze informatie verstrekt.
s.surveylegend.com/-NqgyeOSaTVcd7gBoK15
1 CommentComment on Facebook
💪💪💪
;
